Case Studies
VOC biomarkers – a novel approach to early detection, precision medicine and drug development, that’s already bearing fruit
Across the world, leading breath researchers are breaking ground establishing new clinical and pharmaceutical applications for VOC biomarkers, with much of the most exciting work underpinned by our Breath Biopsy and FAIMS technologies.
These case studies, many of which are from our academic and clinical partners, explore the untapped potential of VOCs across a wide range of disease areas.
There are a virtually unlimited range of applications across early detection and precision medicine for illnesses including respiratory diseases, cancer, gastrointestinal and cardiometabolic disease, as well as exposomics. Contact us to discuss how you can add breath research to your own research.
Using breath analysis to differentiate interstitial lung diseases
Monitoring exercise induced inflammation in IBD patients
Using exhaled methane to diagnose intestinal methanogen overgrowth
Using breath to diagnose invasive fungal diseases
Detection of COVID-19 in breath aerosols
Distinguishing COPD from lung cancer in a large cohort study
Reviewing breath biomarkers for inflammatory respiratory diseases
Is breath acetone too ubiquitous to be a good biomarker of heart failure?
VOCs for bronchoconstriction in asthmatic children
Learn about breath biomarkers and their applications. Download our free ebook.
